Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Worldwide Hysterectomy Device Market is Projected to reach USD 450.5 Million by 2028, at a CAGR of 5.5%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Hysterectomy Device Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Hysterectomy Device Market size is expected to reach $450.5 Million by 2028, rising at a market growth of 5.5% CAGR during the forecast period.

The Fibroids segment is showcasing a CAGR of 5.8% during (2022 - 2028). This is due to the fact that they are exceedingly prevalent and non-cancerous. Myomas or leiomyomas, often known as uterine fibroids, are growths that develop in the uterus, and the uterine muscle makes them. A huge number of individuals with uteruses will experience a diagnosis of fibroids at some point in their lives. The use of a hysterectomy can stop bleeding or discomfort brought on by fibroids which are anticipated to propel the segment's expansion.

The Hospitals segment is leading the Global Hysterectomy Device Market by End User in 2021 thereby, achieving a market value of $256 million by 2028. This is because it serves as a multifunctional place for patients having hysterectomy surgeries by providing diagnoses for detecting illnesses, preoperative treatment, and postoperative care. Hospitals provide patients with higher treatment, and they have to only pay for specific procedures. Also, in hospitals, technologically advanced equipment is widely used to deliver better care.

The Laparoscopic Hysterectomy segment has shown the growth rate of 5.7% during (2022 - 2028). This is due to its increased preference for open surgery, which offers many benefits. Patients generally suffer less pain, leave fewer scars, and recover more quickly. LH patients are typically home the same day or need an overnight stay. More minor, shallower incisions result in little to no blood loss and lower danger of problems such as abdominal infections.

The North America market dominated the Global Hysterectomy Device Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $161.2 million by 2028. The Europe market is exhibiting a CAGR of 4.9% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 6.5% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/hysterectomy-device-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, B. Braun Melsungen AG, ConMed Corporation, Johnson & Johnson, Richard Wolf GmbH, Karl Storz SE & Co. KG, The Cooper Companies, Inc., Laborie Medical Technologies (Patricia Industries) (Investor AB), Fortimedix Surgical B.V., and Conkin Surgical Instruments Ltd.

Global Hysterectomy Device Market Segmentation

By Disease Type

  • Chronic Pelvic Pain
  • Fibroids
  • Uterine Cancer
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Surgical Approach

  • Abdominal Hysterectomy
  • Laparoscopic Hysterectomy
  • Robotic-assisted Laparoscopic Hysterectomy
  • Vaginal Hysterectomy

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Medtronic PLC
  • B.Braun Melsungen AG
  • ConMed Corporation
  • Johnson & Johnson
  • Richard Wolf GmbH
  • Karl Storz SE & Co. KG
  • The Cooper Companies, Inc.
  • Laborie Medical Technologies ( Patricia Industries)(Investor AB)
  • Fortimedix Surgical B.V.
  • Conkin Surgical Instruments Ltd

Related Reports:



SUBSCRIPTION MODEL